Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in overweight subjects with chronic hepatitis C
NCT01157975Phase 2Withdrawn
- Sponsor
- University of California, San Diego
- Start
- Oct 2008
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pioglitazone in hepatitis C (HCV), sponsored by University of California, San Diego. Planned start Oct 2008; status: withdrawn.
02
Drugs
pioglitazone
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01157975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01157975.